Emerald Advisers, LLC Trans Medics Group, Inc. Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

A detailed history of Emerald Advisers, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 150,907 shares of TMDX stock, worth $11.7 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

150,907

Previous 323,350 53.33%

Holding current value

$11.7 Million

Previous $48.7 Million 51.35%

% of portfolio

0.99%

Previous 2.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$135.68 - $176.11 $23.4 Million - $30.4 Million	-172,443 Reduced 53.33%	150,907 $23.7 Million
Q2 2024 Aug 06, 2024	SELL	$72.62 - $150.62 $14.5 Million - $30.1 Million	-200,070 Reduced 38.22%	323,350 $48.7 Million
Q1 2024 May 08, 2024	BUY	$70.86 - $89.93 $500,767 - $635,535	7,067 Added 1.37%	523,420 $38.7 Million
Q4 2023 Feb 05, 2024	BUY	$36.74 - $81.08 $2.71 Million - $5.98 Million	73,807 Added 16.68%	516,353 $40.8 Million
Q3 2023 Oct 26, 2023	BUY	$53.47 - $96.07 $345,041 - $619,939	6,453 Added 1.48%	442,546 $24.2 Million
Q2 2023 Jul 25, 2023	BUY	$66.23 - $88.73 $366,980 - $491,652	5,541 Added 1.29%	436,093 $36.6 Million
Q1 2023 May 04, 2023	SELL	$53.63 - $82.33 $7.09 Million - $10.9 Million	-132,115 Reduced 23.48%	430,552 $32.6 Million
Q4 2022 Feb 03, 2023	BUY	$39.08 - $64.29 $2.65 Million - $4.36 Million	67,741 Added 13.69%	562,667 $34.7 Million
Q3 2022 Oct 25, 2022	BUY	$31.56 - $55.75 $3.07 Million - $5.43 Million	97,361 Added 24.49%	494,926 $20.7 Million
Q2 2022 Jul 29, 2022	BUY	$20.56 - $32.15 $2.4 Million - $3.75 Million	116,612 Added 41.51%	397,565 $12.5 Million
Q1 2022 Apr 29, 2022	BUY	$12.58 - $26.94 $454,603 - $973,530	36,137 Added 14.76%	280,953 $7.57 Million
Q4 2021 Feb 02, 2022	SELL	$19.16 - $32.68 $164,047 - $279,806	-8,562 Reduced 3.38%	244,816 $4.69 Million
Q3 2021 Oct 28, 2021	SELL	$25.92 - $34.51 $1.22 Million - $1.62 Million	-47,086 Reduced 15.67%	253,378 $8.38 Million
Q2 2021 Jul 29, 2021	SELL	$21.63 - $40.07 $6.59 Million - $12.2 Million	-304,511 Reduced 50.33%	300,464 $9.97 Million
Q1 2021 Apr 29, 2021	SELL	$17.75 - $47.82 $1.21 Million - $3.25 Million	-67,905 Reduced 10.09%	604,975 $25.1 Million
Q4 2020 Jan 29, 2021	BUY	$11.91 - $19.9 $258,411 - $431,770	21,697 Added 3.33%	672,880 $13.4 Million
Q3 2020 Oct 28, 2020	SELL	$13.78 - $18.84 $251,953 - $344,470	-18,284 Reduced 2.73%	651,183 $8.97 Million
Q2 2020 Jul 28, 2020	BUY	$11.66 - $18.26 $2.52 Million - $3.95 Million	216,389 Added 47.76%	669,467 $12 Million
Q1 2020 Apr 30, 2020	BUY	$10.5 - $20.2 $16,128 - $31,027	1,536 Added 0.34%	453,078 $5.47 Million
Q4 2019 Jan 29, 2020	BUY	$16.61 - $21.64 $4.04 Million - $5.26 Million	243,034 Added 116.56%	451,542 $8.58 Million
Q3 2019 Oct 31, 2019	SELL	$20.27 - $28.93 $60,810 - $86,790	-3,000 Reduced 1.42%	208,508 $4.95 Million
Q2 2019 Jul 31, 2019	BUY	$22.36 - $30.41 $4.73 Million - $6.43 Million	211,508 New	211,508 $6.13 Million

Others Institutions Holding TMDX

# of Institutions

396

Shares Held

31.9M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.46B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Trans Medics Group, Inc. Transaction History